FDA's determination of the safety and effectiveness of a diagnostic radiopharmaceutical includes consideration of the following:
The proposed use of the diagnostic radiopharmaceutical in the practice of medicine;
The pharmacological and toxicological activity of the diagnostic radiopharmaceutical (including any carrier or ligand component of the diagnostic radiopharmaceutical); and
The estimated absorbed radiation dose of the diagnostic radiopharmaceutical.